Geron Corporation (GERN) news: Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary - Seeking Alpha
Here is a great article by the Stock Doctor about why Geron (GERN) has been unfairly hit by an FDA hold. The curing properties that Imetelstat has makes it worthwhile as a drug, and as people commented at the end of the article, liver problems can occur with many prescription medications as well as over-the-counter products. I am adding to my position in Geron because I think the author is right that the company will double as a minimum from here, and it will probably be a multi-bagger stock in the future.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment